The genius of Clinpal is in the details. Find out more.

Case Studies

Phase 3 Study involving Social Media Recruitment, eConsent and Bring Your Own Device ePRO

Phase 3 Study involving Social Media Recruitment, eConsent and Bring Your Own Device ePRO

Background
  • More than 1,000 patients pre-screened in under 4 weeks
  • Electronic informed consent / assent for volunteers, parents and guardians aged 13 and over
  • Daily Diary for 12 months

  • Learn More
Patient Questionnaires in a Depression Study

Patient Questionnaires in a Depression Study

Background
  • Clinpal supporting 120 patients over 18 months
  • Hybrid study combining visits, telephone visit and intervention at home with self-reporting
  • Digital theraputic to be delivered via smartphone
  • Data collected
    Learn More
Global Registries in Cardiovascular

Global Registries in Cardiovascular

Background
  • Clinpal deployed in two registries with 10,000 and 6,000 patients
  • Deployed in 41 countries
  • Launched in 2015, study is ongoing
  • Advanced dynamic eCRF reduced monitoring and site work
    Learn More
Decentralized Diabetes Study

Decentralized Diabetes Study

Background
  • Decentralized, remote diabetes study assessing the insulin efficacy against food intake, sleep and exercise
  • Combined electronic Blood Glucose meter (3G) backed by cloud services
  • Online patient recruitment only

  • Learn More

Selected Clinpal Deployments

CLIENTINDICATIONPHASEDESCRIPTIONCOUNTRIES
TOP 10 PHARMADiabetesIVFully remote, online trial, using a SMART glucose meter integrated with Clinpal to capture blood glucose measurements in real time. 50 patients,1 study site. Study completed with excellent results. Click here to request more informationFI
TOP 10 PHARMAThrombosisN/ABring Your Own Device (BYOD) eCOA validation study. Scientific work to develop a methodology and validate an ePRO patient questionnaire for use with patient’s own devices. Involving 25 patients in Spain and Finland.ES, FI
TOP 10 PHARMAAsthmaIIISite engagement portal with e-Learning, and site documents. Deployed to 140 sites, covering 10 e-Learning modules and an extensive document library with over 15 folders.RU, BG, ZA, NZ, UA, BR, AU, SK, GB, PL, RO, US, CA, GE
TOP 10 PHARMAAsthmaIIIModerate to severe asthma and other related indications. Clinpal is utilized across this important program as the patient recruitment and engagement solution as well as a site portal. Several studies, 2,000+ patients, 400+ sites in 8 countries.US, CA, MX, JP, AU, ZA, GB, UA
TOP 10 PHARMA & RESEARCH INSTITUTEThrombosisIV10,000 patient registry study, 500 sites, 28 countries. Clinpal is used as a comprehensive data capture solution, including eCRF’s, electronic patient questionnaires and site support features.GB, US, CZ, IT, RU, ZA, DE, CA, TH, NL, DK, TW, AU, KR, MY, HK, CN, AR, CH, TR, AE, BE, JP, MX, ES, EG, FR, BR
TOP 10 PHARMA & RESEARCH INSTITUTEThrombosisIV5,000 patient registry study, 700 sites, 18 countries. Clinpal is used as a comprehensive data capture solution, including eCRF’s, electronic patient questionnaires and site support features.GB, PL, NL, AU, RU, DK, DE, SA, IT, AE, FR, ES, EG, CA, SE, BR, NO, MX
TOP 10 PHARMA & GOVERNMENTAL RESEARCH SERVICESDiabetesIV900 patient Diabetes registry. In a unique EHR/EMR integration study, Clinpal is used to recruit sites and patients based on a pre-qualification of candidates from an interface with national electronic medical records.GB
Clinpal is used for candidate assessment screening, randomization, letter production and patient (ePRO) questionnaires for direct eSource data capture and integrated Protocol and GCP eLearning. Clinpal utilizes CDISC standard for data interchange.
MEDICAL DEVICE COMPANYGlaucomaIV500 patient registry study for a medical device company. Using Clinpal for site training and data capture.FR, BE, ES, DE, CH
BIOTECHNOLOGY COMPANYObesityIVInnovative observatory study involving 300 patients in 4 countries. Clinpal is used for patient recruitment and engagement as well as data capture directly from patients using biometric devices, electronic patient reported outcomes (ePRO) and eCRFs.FR, US, IT, BE
BIOTECHNOLOGYCystic FibrosisMethodologyA methodology study that incorporates several novel aspects of clinical trial conduct. Clinpal is used to support electronic informed consent, consolidation of audiometric tests, eSource data capture directly from patients, patient questionnaires, ePRO validation, and a patient-centric reward program that gamifies the clinical trial experience.US
MID SIZED PHARMAObesityIVDesign of a patient engagement platform to support a long term nutritional observational study.US
BIOTECHNOLOGYOncologyIVObservational study assessing inner health in 100 adult patients recruited in Australia who have received or are currently receiving anti-cancer medications. Clinpal is used for patient recruitment and engagement as well as data capture directly from patients using biometric devices, electronic patient reported outcomes (ePRO) and eCRFs.AU
DIGITAL THERAPEUTICSCNS / DepressionII100% remote randomized study with 120 participants and a single virtual site consisting of the investigator and a study therapist. The objective is to evaluate the efficacy of a digital therapy app for the treatment of depression and anxiety.FI
BIOTECHNOLOGYCystic FibrosisIVScientific review and usability evaluation of a battery of eCOA / ePRO instruments in advance of deployment into a clinical trial.USA
RESEARCH INSTITUTEOncologyIDigital patient outreach and recruitment solution for a challenging oncology trial.ES, FR
CONSUMER PRODUCTS COMPANYNutritionValidation StudyUsability testing and validation of a new eCOA instrument that measures the efficacy of a functional food product for infants.GB
CLINICAL RESEARCH ORGANISATION (CRO)Women’s HealthIIIPatient engagement and site engagement portals with eLearning, eConsent, ePRO and various patient engagement functionality. Deployed at 50 sites to 900 patients.US, CA
CALL CENTER PARTNEROphthalmologyHEORHealth economics and outcomes research project with 100 patients, supporting patient identification and enrollment.US, CA
TOP 10 PHARMAAutoimmune disorderValidation StudyNon-interventional, multicenter, instrument validation study with 1,500 patients.GB